FDA Orange Book · active-ingredient family
Angiotensin ii acetate
Angiotensin ii acetate is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:GIAPREZA · NDA 209360
1
Brand (NDA)
1
Generics (ANDA)
11
Listed patents
0
Exclusivity periods
Brand (NDA) products · solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| GIAPREZARLD×3 | LA JOLLA PHARMA | NDA 209360 | — | Dec 23, 2021 |
Generic (ANDA) products (1)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ANGIOTENSIN ll ACETATE | GLAND | ANDA 216966 | AP | Jun 03, 2025 |
Listed patents (11)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10500247 | Dec 16, 2029 | in 3 yr 7 mo | U-2681 |
| 10548943 | Dec 16, 2029 | in 3 yr 7 mo | U-2740 |
| 10335451 | Dec 16, 2029 | in 3 yr 7 mo | U-2581 |
| 9867863 | Dec 16, 2029 | in 3 yr 7 mo | U-2231 |
| 9572856 | Jul 18, 2031 | in 5 yr 2 mo | U-2221 |
| 11559559 | Dec 18, 2034 | in 8 yr 7 mo | U-3514 |
| 10493124 | Dec 18, 2034 | in 8 yr 7 mo | U-2679 |
| 11096983 | Dec 18, 2034 | in 8 yr 7 mo | U-3212 |
| 10028995 | Dec 18, 2034 | in 8 yr 7 mo | U-2338 |
| 9220745 | Dec 18, 2034 | in 8 yr 7 mo | U-2217 |
| 11219662 | Jan 06, 2037 | in 10 yr 8 mo | U-3262 |
Angiotensin ii acetate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
